Enfermedad vascular periférica (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Enfermedad vascular periférica" in Spanish language version.

refsWebsite

Global rank Spanish rank

13nih.gov

4^th place

10doi.org

2^nd place

2web.archive.org

1^st place

1diabetesjournals.org

low place

9,811^th place

1tasc-2-pad.org

low place

1guideline.gov

low place

1worldwidewounds.com

low place

1archive.org

6^th place

5^th place

archive.org

Leiner T, Kessels AG, Nelemans PJ, Vasbinder GB, de Haan MW, Kitslaar PE, Ho KY, Tordoir JH, van Engelshoven JM699-708 (mayo de 2005). «Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis». Radiology 235 (2): 699-708. PMID 15858107. doi:10.1148/radiol.2352040089.

diabetesjournals.org

care.diabetesjournals.org

Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR (abril de 2006). «HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study». Diabetes Care 29 (4): 877-82. PMID 16567831. doi:10.2337/diacare.29.04.06.dc05-2018.

doi.org

dx.doi.org

Shammas NW (2007). «Epidemiology, classification, and modifiable risk factors of peripheral arterial disease». Vasc Health Risk Manag 3 (2): 229-34. PMC 1994028. PMID 17580733. doi:10.2147/vhrm.2007.3.2.229.
Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR (abril de 2006). «HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study». Diabetes Care 29 (4): 877-82. PMID 16567831. doi:10.2337/diacare.29.04.06.dc05-2018.
TASC II Guidelines
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg. 33 (Suppl 1): S1-75. PMID 17140820. doi:10.1016/j.ejvs.2006.09.024. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group et al. (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». J Vasc Surg. 45 (Suppl S): S5-67. PMID 17223489. doi:10.1016/j.jvs.2006.12.037. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease». Int Angiol. 26 (2): 81-157. PMID 17489079. Archivado desde el original el 21 de febrero de 2014.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal, Curtis W., Creager, Mark A., Halperin, Jonathan L., Hiratzka, Loren F., Murphy, William R.C., Olin, Jeffrey W. (2006). «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol. 47 (6): 1239-312. PMID 16545667. doi:10.1016/j.jacc.2005.10.009. Archivado desde el original el 11 de enero de 2009. Consultado el 29 de mayo de 2014.
Leiner T, Kessels AG, Nelemans PJ, Vasbinder GB, de Haan MW, Kitslaar PE, Ho KY, Tordoir JH, van Engelshoven JM699-708 (mayo de 2005). «Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis». Radiology 235 (2): 699-708. PMID 15858107. doi:10.1148/radiol.2352040089.
Burns P, Gough S, Bradbury AW (marzo de 2003). «Management of peripheral arterial disease in primary care». BMJ 326 (7389): 584-8. PMC 1125476. PMID 12637405. doi:10.1136/bmj.326.7389.584.
Robless P, Mikhailidis DP, Stansby GP (2008). «Cilostazol for peripheral arterial disease». En Robless, Peter, ed. Cochrane Database Syst Rev (1): CD003748. PMID 18254032. doi:10.1002/14651858.CD003748.pub3.
Salhiyyah, Kareem; Senanayake, Eshan; Abdel-Hadi, Mohammed; Booth, Andrew; Michaels, Jonathan A (2012). Pentoxifylline for intermittent claudication. En Salhiyyah, Kareem, ed. «Cochrane Database of Systematic Reviews». Cochrane Database Syst Rev 1: CD005262. PMID 22258961. doi:10.1002/14651858.CD005262.pub2.
Fowkes FG, Gillespie IN (2000). «Angioplasty (versus non surgical management) for intermittent claudication». En Fowkes, Gerry, ed. Cochrane Database Syst Rev (2): CD000017. PMID 10796469. doi:10.1002/14651858.CD000017.
Twine CP, Coulston J, Shandall A, McLain AD (2009). «Angioplasty versus stenting for superficial femoral artery lesions». En Twine, Christopher P, ed. Cochrane Database Syst Rev (2): CD006767. PMID 19370653. doi:10.1002/14651858.CD006767.pub2.

guideline.gov

Hirsch AT, Haskal ZJ, Hertzer NR, Bakal, Curtis W., Creager, Mark A., Halperin, Jonathan L., Hiratzka, Loren F., Murphy, William R.C., Olin, Jeffrey W. (2006). «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol. 47 (6): 1239-312. PMID 16545667. doi:10.1016/j.jacc.2005.10.009. Archivado desde el original el 11 de enero de 2009. Consultado el 29 de mayo de 2014.

nih.gov

ncbi.nlm.nih.gov

Shammas NW (2007). «Epidemiology, classification, and modifiable risk factors of peripheral arterial disease». Vasc Health Risk Manag 3 (2): 229-34. PMC 1994028. PMID 17580733. doi:10.2147/vhrm.2007.3.2.229.
Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR (abril de 2006). «HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study». Diabetes Care 29 (4): 877-82. PMID 16567831. doi:10.2337/diacare.29.04.06.dc05-2018.
Fontaine R, Kim M, Kieny R (1954). «Die chirugische Behandlung der peripheren Durchblutungsstörungen. (Surgical treatment of peripheral circulation disorders)». Helvetica Chirurgica Acta (en alemán) 21 (5/6): 499-533. PMID 14366554.
TASC II Guidelines
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg. 33 (Suppl 1): S1-75. PMID 17140820. doi:10.1016/j.ejvs.2006.09.024. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group et al. (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». J Vasc Surg. 45 (Suppl S): S5-67. PMID 17223489. doi:10.1016/j.jvs.2006.12.037. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease». Int Angiol. 26 (2): 81-157. PMID 17489079. Archivado desde el original el 21 de febrero de 2014.
Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012 Oct 24;308(16):1660-7. doi: 10.1001/jama.2012.13415 PMID 23093164
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal, Curtis W., Creager, Mark A., Halperin, Jonathan L., Hiratzka, Loren F., Murphy, William R.C., Olin, Jeffrey W. (2006). «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol. 47 (6): 1239-312. PMID 16545667. doi:10.1016/j.jacc.2005.10.009. Archivado desde el original el 11 de enero de 2009. Consultado el 29 de mayo de 2014.
Leiner T, Kessels AG, Nelemans PJ, Vasbinder GB, de Haan MW, Kitslaar PE, Ho KY, Tordoir JH, van Engelshoven JM699-708 (mayo de 2005). «Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis». Radiology 235 (2): 699-708. PMID 15858107. doi:10.1148/radiol.2352040089.
Leiner, T (febrero de 2005). «Magnetic resonance angiography of abdominal and lower extremity vasculature». Top Magn Reson Imaging 16 (1): 21-66. PMID 16314696.
Burns P, Gough S, Bradbury AW (marzo de 2003). «Management of peripheral arterial disease in primary care». BMJ 326 (7389): 584-8. PMC 1125476. PMID 12637405. doi:10.1136/bmj.326.7389.584.
Robless P, Mikhailidis DP, Stansby GP (2008). «Cilostazol for peripheral arterial disease». En Robless, Peter, ed. Cochrane Database Syst Rev (1): CD003748. PMID 18254032. doi:10.1002/14651858.CD003748.pub3.
Salhiyyah, Kareem; Senanayake, Eshan; Abdel-Hadi, Mohammed; Booth, Andrew; Michaels, Jonathan A (2012). Pentoxifylline for intermittent claudication. En Salhiyyah, Kareem, ed. «Cochrane Database of Systematic Reviews». Cochrane Database Syst Rev 1: CD005262. PMID 22258961. doi:10.1002/14651858.CD005262.pub2.
Fowkes FG, Gillespie IN (2000). «Angioplasty (versus non surgical management) for intermittent claudication». En Fowkes, Gerry, ed. Cochrane Database Syst Rev (2): CD000017. PMID 10796469. doi:10.1002/14651858.CD000017.
Twine CP, Coulston J, Shandall A, McLain AD (2009). «Angioplasty versus stenting for superficial femoral artery lesions». En Twine, Christopher P, ed. Cochrane Database Syst Rev (2): CD006767. PMID 19370653. doi:10.1002/14651858.CD006767.pub2.

tasc-2-pad.org

TASC II Guidelines
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg. 33 (Suppl 1): S1-75. PMID 17140820. doi:10.1016/j.ejvs.2006.09.024. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group et al. (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». J Vasc Surg. 45 (Suppl S): S5-67. PMID 17223489. doi:10.1016/j.jvs.2006.12.037. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease». Int Angiol. 26 (2): 81-157. PMID 17489079. Archivado desde el original el 21 de febrero de 2014.

web.archive.org

TASC II Guidelines
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg. 33 (Suppl 1): S1-75. PMID 17140820. doi:10.1016/j.ejvs.2006.09.024. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group et al. (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». J Vasc Surg. 45 (Suppl S): S5-67. PMID 17223489. doi:10.1016/j.jvs.2006.12.037. Archivado desde el original el 21 de febrero de 2014.
* Norgren L, Hiatt WR, Dormandy JA (2007). «Inter-Society Consensus for the Management of Peripheral Arterial Disease». Int Angiol. 26 (2): 81-157. PMID 17489079. Archivado desde el original el 21 de febrero de 2014.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal, Curtis W., Creager, Mark A., Halperin, Jonathan L., Hiratzka, Loren F., Murphy, William R.C., Olin, Jeffrey W. (2006). «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol. 47 (6): 1239-312. PMID 16545667. doi:10.1016/j.jacc.2005.10.009. Archivado desde el original el 11 de enero de 2009. Consultado el 29 de mayo de 2014.

worldwidewounds.com

Vowden P, Vowden K (marzo de 2001). «Doppler assessment and ABPI: Interpretation in the management of leg ulceration». Worldwide Wounds. - describes ABPI procedure, interpretation of results, and notes the somewhat arbitrary selection of "ABPI of 0.8 has become the accepted endpoint for high compression therapy, the trigger for referral for a vascular surgical opinion and the defining upper marker for an ulcer of mixed aetiology"